PHAT - Phathom Pharmaceuticals, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.09
|
Rev Est: $57.4M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$22.40
DETAILS
HIGH:
$28.00
LOW:
$16.00
MEDIAN:
$22.00
CONSENSUS:
$22.40
UPSIDE:
92.94%
Market Cap:
905.74M
Volume:
778,945
Avg Volume:
1,052,745
52 Week Range:
2.21-18.31
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.50
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
427
IPO Date:
2019-10-25
EPS (TTM):
-5.29
P/E Ratio:
-1.53
Revenue (TTM):
55.25M
Total Assets:
378.32M
Total Debt:
554.95M
Cash & Equiv:
297.26M
Rev Growth (5Y):
8001.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-89.7%
Debt/Equity:
-2.19
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-10-30 | $-0.15 | $-0.30 | +50.0% | $49.5M | $57.4M | -13.8% |
| 2025-08-07 | $-0.79 | $-0.76 | -3.9% | $39.5M | $46.8M | -15.5% |
| 2025-05-01 | $-1.07 | $-1.06 | -0.9% | $28.5M | $35.6M | -20.0% |
| 2025-03-06 | $-0.79 | $-1.29 | +38.8% | $29.7M | $29.0M | +2.2% |
| 2024-11-07 | $-1.32 | $-1.57 | +15.9% | $16.4M | $25.8M | -36.5% |
| 2024-08-08 | $-1.25 | $-1.20 | -4.2% | $7.3M | $5.8M | +26.1% |
| 2024-05-09 | $-1.42 | $-1.43 | +0.7% | $1.9M | $2.0M | -6.7% |
| 2024-03-07 | $-0.80 | $-0.92 | +13.0% | $682000 | $410000 | +66.3% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 55.25M | 682,000 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (334.33M) | (201.59M) | (197.72M) | (143.88M) | (129.07M) | (209.74M) | (1.29M) |
| EPS | -5.29 | -3.93 | -5.70 | -4.00 | -4.01 | -8.48 | -0.15 |
| Total Assets | 378.32M | 413.84M | 164.81M | 189.43M | 295.11M | 257.18M | 902,000 |
| Total Debt | 554.95M | 139.03M | 97.07M | 91.34M | 49.02M | 23.57M | 1.95M |
| Cash & Equivalents | 297.26M | 381.39M | 155.38M | 183.26M | 287.50M | 243.76M | 879,000 |
| Operating Cash Flow | (266.77M) | (137.58M) | (146.53M) | (148.46M) | (69.69M) | (36.51M) | (1.02M) |
| Free Cash Flow | (266.90M) | (139.21M) | (147.57M) | (148.78M) | (70.73M) | (61.76M) | (1.02M) |
| FCF per Share | -4.22 | -2.71 | -3.77 | -4.02 | -2.13 | -2.50 | -0.12 |
| Book Value | (253.58M) | (72.76M) | (74.81M) | 72.16M | 194.27M | 227.96M | (1.29M) |
| Cash & ST Investments | 297.26M | 381.39M | 155.38M | 183.26M | 287.50M | 243.76M | 879,000 |
| ROC Equity | N/A | N/A | N/A | -1.99 | -0.66 | -0.92 | N/A |